Projects per year
Personal profile
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Carlos Graux is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Etude miR-126 impliqué en oncogenèse
Muylkens, B., Graux, C., George, F. & Finet, L.
1/12/13 → …
Project: Research
-
Test sanguin de détection/pronostic de cancer
POPA, C., De Ronde, T., Rahier, J., D'Hondt, L., Graux, C., George, F., Finet, L. & Herzog, M.
1/12/13 → …
Project: Research
-
Etude de l’effet potentiel de macrophages sur la cytotoxicité de molécules chimiothérapeutiques vis-à-vis de cellules cancéreuses
Graux, C., MICHIELS, C. & GENIN, M.
1/12/13 → 30/09/14
Project: Research
-
Télévie: Etude de la résistance des tumeurs aux agents utilisés en chimiothérapie : caractérisation et validation d’un gène candidat
MICHIELS, C., Graux, C., D'Hondt, L., George, F. & Finet, L.
1/12/13 → 30/09/16
Project: Research
Research output
-
Evaluation of the Selectivity of BCR-ABL Tyrosine Kinase Inhibitors (TKIs): A Systematic Review
Haguet, H., Challe, C., Nezzar, Y., MULLIER, F., Graux, C., DOGNE, J-M. & DOUXFILS, JONATHAN., 12 Jul 2020.Research output: Contribution to conference › Poster › peer-review
-
In vitro Evaluation of the Impact of BCR-ABL Tyrosine Kinase Inhibitors on Atherosclerosis Plaque Rupture
Haguet, H., MULLIER, F., Graux, C., DOGNE, J-M. & DOUXFILS, JONATHAN., 12 Jul 2020.Research output: Contribution to conference › Poster › peer-review
-
In vitro investigation of the impact of BCR-ABL Tyrosine Kinase Inhibitors on endothelial cells
Haguet, H., MULLIER, F., Graux, C., DOGNE, J-M. & DOUXFILS, JONATHAN., 12 Jul 2020.Research output: Contribution to conference › Poster › peer-review
-
Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis
Haguet, H., Graux, C., Mullier, F., Dogné, J-M. & Douxfils, J., 15 May 2020, In: Cancers. 12, 5, 15 p., 1242.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia
Favresse, J., Eucher, C., Elsen, M., Graux, C., Goebels, P., Laffineur, K., Nicolas, J-B., Dogné, J-M. & Douxfils, J., 1 Aug 2020, In: British Journal of Haematology. 190, 4, p. e187-e189Research output: Contribution to journal › Article › peer-review
Open AccessFile
Datasets
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), CHATELAIN, C. (Contributor), MULLIER, F. (Contributor), Haguet, H. (Contributor), DOGNE, J. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
Activities
- 6 Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker), François Mullier (Speaker) & Jean-Michel Dogne (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
25 Feb 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
29 Jan 2016Activity: Talk or presentation types › Oral presentation
Press / Media
-
Volition Creates Clinical Evaluation Committee
14/11/11 → 16/11/11
2 items of Media coverage
Press/Media: Expert Comment